Accent MicrocellNSE:ACCENTMIC +4.17%30 Gross Margin % is 37.91% as of Mar. 2025, which is at its 10-year median of 37.91. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 30/100. The stock has 6 warning signs investors should review. Among 943 Drug Manufacturers companies, Accent Microcell ranks worse than 68.82% on this metric.
The historical rank and industry rank for Accent Microcell's Gross Margin % or its related term are showing as below:
NSE:ACCENTMIC'
s Gross Margin % Range Over the Past 10 Years
Min: 29.49 Med: 37.91 Max: 39.63
Current: 37.91
During the past 5 years, the highestGross Margin % of Accent Microcell was 39.63%. The lowest was 29.49%. And the median was 37.91%.
NSE:ACCENTMIC's Gross Margin % is ranked worse than 68.82% of 943
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs NSE:ACCENTMIC: 37.91
Accent Microcell had a gross margin of 37.91% for the quarter that ended in Mar. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Accent Microcell was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Accent Microcell had a gross margin of 37.91% for the quarter that ended in Mar. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Accent Microcell Gross Margin % Related Terms
Accent Microcell Gross Margin % Historical Data
* Premium members only.
The historical data trend for Accent Microcell's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell Gross Margin % Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Gross Margin %
29.49
30.12
38.37
39.63
37.91
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Gross Margin %
29.49
30.12
38.37
39.63
37.91
NSE:ACCENTMIC vs ZTS, UTHR: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Accent Microcell (NSE:ACCENTMIC) has a Gross Margin % of 37.91% as of Mar. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Accent Microcell and its competitors. This is near median its historical median of 37.91. Over the past decade, Accent Microcell's Gross Margin % has ranged from 29.49 to 39.63. According to the industry distribution chart, Accent Microcell ranks #649 out of 943 companies in the Drug Manufacturers industry, placing it in the top 68.8%.
Is Accent Microcell's Gross Margin % too high?
Accent Microcell's current Gross Margin % of 37.91% is near median its 10-year median of 37.91. Over the past 10 years, this metric has ranged from a low of 29.49 to a high of 39.63. The Drug Manufacturers industry median Gross Margin % is 48.54. Accent Microcell's value of 37.91% is 21.9% below this industry median. Based on the distribution chart, Accent Microcell ranks #649 out of 943 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Accent Microcell has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #649 out of 943 companies for Gross Margin %. This places Accent Microcell in the lower half of its industry. The industry median Gross Margin % is 48.54. Accent Microcell's value of 37.91% is 21.9% below this benchmark. Historically, Accent Microcell's own Gross Margin % has ranged from 29.49 to 39.63 over the past decade. While the company's 10-year median is 37.91 vs. the industry median of 48.54, Accent Microcell has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current Gross Margin % of 37.91% is 21.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current Gross Margin % is 37.91%, which is near median its own 10-year median of 37.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current Gross Margin % of 37.91%. The current Gross Margin % is 37.91%, which is near median its 10-year median of 37.91 and 21.9% below the Drug Manufacturers industry median of 48.54. Accent Microcell's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current Gross Margin % is 37.91% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
30GF Score
Get the complete analysis for NSE:ACCENTMIC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 